Dianeal Pd-2/1.5
Dianeal PD-2/1.5% is a sterile peritoneal dialysis solution used to remove waste products and excess fluid from the blood when the kidneys can no longer perform this function adequately. It is designed for patients with end-stage renal disease who require dialysis, and works by infusing into the abdominal cavity where it utilizes the peritoneum as a natural filtering membrane. The 1.5% dextrose concentration provides a specific osmotic gradient to facilitate fluid and toxin removal.
Dianeal PD-2/1.5% is a peritoneal dialysis solution used to cleanse the blood of waste products and excess fluid in patients with kidney failure.
Key facts at a glance
- RxNorm
- 800058
- Generic
- Dianeal Pd-2/1.5
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Dianeal PD-2/1.5% is indicated for the treatment of end-stage renal disease (ESRD) and acute kidney injury. It is used in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD) as a long-term renal replacement therapy.
The solution is infused into the peritoneal cavity through a permanently placed catheter. Dextrose in the solution creates an osmotic gradient that pulls waste products, electrolytes, and excess fluid from the blood vessels lining the peritoneum into the dialysis solution. After a dwell period, the fluid is drained and replaced with fresh solution, repeating the process continuously.
Dianeal PD-2 should only be used under medical supervision by trained healthcare providers or patients who have been properly instructed. The solution must be at body temperature before use. Potential complications include peritonitis, catheter-related infections, fluid imbalances, and electrolyte abnormalities. It is contraindicated in patients with abdominal adhesions, active abdominal infections, or recent abdominal surgery. Patients should follow their prescribed dialysis regimen exactly as directed and report any signs of infection, cloudy drainage fluid, or unusual symptoms to their healthcare provider immediately.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy